Health Check: How Prudently Does ABIVAX Société Anonyme (EPA:ABVX) Use Debt?
Apr 07
Have your own idea? Try our Stock Screener
French (CAC) Biotech Industry Analysis
UpdatedApr 15, 2025
DataAggregated Company Financials
Companies27
- 7D7.8%
- 3M-5.6%
- 1Y-36.4%
- YTD-9.2%
Over the last 7 days, the Biotech industry has remained flat, although notably Poxel gained 157%. As for the longer term, the industry has declined 40% in the last year. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Apr 2025 | €2.2b | €650.8m | -€549,229,167.55 | 14.1x | -4.1x | 3.4x |
| Thu, 13 Mar 2025 | €2.3b | €651.7m | -€520,359,851.81 | 16.6x | -4.5x | 3.6x |
| Sat, 08 Feb 2025 | €2.4b | €650.4m | -€528,002,583.50 | 16.3x | -4.6x | 3.7x |
| Mon, 06 Jan 2025 | €2.4b | €650.7m | -€528,615,557.34 | 18.5x | -4.5x | 3.7x |
| Wed, 04 Dec 2024 | €2.4b | €654.3m | -€548,189,251.43 | 18.1x | -4.3x | 3.6x |
| Fri, 01 Nov 2024 | €2.8b | €640.9m | -€517,986,963.58 | 18.8x | -5.4x | 4.4x |
| Sun, 29 Sep 2024 | €2.9b | €640.6m | -€509,140,447.82 | 19.6x | -5.6x | 4.5x |
| Tue, 27 Aug 2024 | €3.1b | €520.2m | -€578,934,243.44 | 37.2x | -5.4x | 6x |
| Thu, 25 Jul 2024 | €2.9b | €511.8m | -€567,032,346.37 | 29.2x | -5.1x | 5.7x |
| Sat, 22 Jun 2024 | €3.0b | €514.4m | -€569,641,165.19 | 26.4x | -5.2x | 5.8x |
| Mon, 20 May 2024 | €3.3b | €502.3m | -€592,424,218.48 | 27.9x | -5.6x | 6.6x |
| Wed, 17 Apr 2024 | €3.3b | €515.7m | -€629,721,423.09 | 27.6x | -5.2x | 6.3x |
| Fri, 15 Mar 2024 | €3.1b | €567.9m | -€645,961,276.84 | 21.4x | -4.8x | 5.4x |
| Sun, 11 Feb 2024 | €3.0b | €558.9m | -€674,772,026.21 | 22.1x | -4.4x | 5.4x |
| Tue, 09 Jan 2024 | €3.2b | €594.2m | -€682,901,948.00 | 23.5x | -4.7x | 5.4x |
| Thu, 07 Dec 2023 | €3.2b | €594.7m | -€685,625,024.00 | 22x | -4.7x | 5.4x |
| Sat, 04 Nov 2023 | €3.3b | €803.3m | -€564,210,227.00 | 21.2x | -5.9x | 4.1x |
| Mon, 02 Oct 2023 | €3.6b | €850.1m | -€630,409,790.00 | 14.2x | -5.6x | 4.2x |
| Wed, 30 Aug 2023 | €3.8b | €818.0m | -€726,469,920.00 | 24.1x | -5.2x | 4.6x |
| Fri, 28 Jul 2023 | €3.8b | €817.8m | -€735,672,254.00 | 24.4x | -5.2x | 4.7x |
| Sun, 25 Jun 2023 | €3.9b | €820.0m | -€744,113,037.00 | 25.4x | -5.2x | 4.7x |
| Tue, 23 May 2023 | €3.8b | €831.2m | -€761,596,854.00 | 26.2x | -4.9x | 4.5x |
| Thu, 20 Apr 2023 | €3.5b | €878.4m | -€769,324,477.00 | 33.5x | -4.6x | 4x |
| Sat, 18 Mar 2023 | €3.3b | €1.0b | -€480,685,245.00 | 9.5x | -6.8x | 3.2x |
| Mon, 13 Feb 2023 | €3.7b | €1.0b | -€457,266,031.00 | 11.5x | -8.1x | 3.5x |
| Wed, 11 Jan 2023 | €3.7b | €1.0b | -€454,453,867.00 | 12.2x | -8.2x | 3.6x |
| Fri, 09 Dec 2022 | €3.4b | €1.0b | -€457,466,832.00 | 12.5x | -7.5x | 3.3x |
| Sun, 06 Nov 2022 | €3.5b | €912.9m | -€704,376,648.00 | 16.4x | -5x | 3.9x |
| Tue, 04 Oct 2022 | €3.3b | €924.0m | -€677,389,706.00 | 30.6x | -4.9x | 3.6x |
| Thu, 01 Sep 2022 | €4.3b | €928.9m | -€749,967,936.00 | 114.5x | -5.8x | 4.7x |
| Sat, 30 Jul 2022 | €4.3b | €983.0m | -€689,206,520.00 | 120.9x | -6.3x | 4.4x |
| Mon, 27 Jun 2022 | €4.7b | €993.1m | -€693,029,894.00 | 126x | -6.7x | 4.7x |
| Wed, 25 May 2022 | €4.5b | €989.2m | -€688,761,014.00 | 135.9x | -6.5x | 4.6x |
| Fri, 22 Apr 2022 | €5.0b | €1.2b | -€488,759,373.00 | 2.9x | -10.3x | 4.1x |
Price to Earnings Ratio
-10.3x
Current Industry PE
- Investors are pessimistic on the French Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.6x is higher than the industry's current PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 19% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 5.37% | |
| Healthcare | 3.83% | |
| Biotech | 7.81% | |
| Biotech | 7.81% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| VLA Valneva | €3.19 | 14.2% +€64.6m | -20.5% | PS3.1x | |
| ABVX ABIVAX Société Anonyme | €5.36 | 10.5% +€32.3m | -61.7% | PS31.5x | |
| ALCLS Cellectis | €1.42 | 27.1% +€21.8m | -40.2% | PS2.4x | |
| ALERS Eurobio Scientific Société anonyme | €24.71 | 6.0% +€14.1m | 63.0% | PE37.4x | |
| POXEL Poxel | €0.46 | 128.3% +€13.9m | -29.4% | PS11.3x |
